Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?

Published:2023-05-31 Issue:6 Volume:27 Page:454-455
ISSN:0972-5229
Container-title:Indian Journal of Critical Care Medicine
language:en
Short-container-title:

Author:

Salhotra Ripenmeet

Publisher

Jaypee Brothers Medical Publishing

Subject

Critical Care and Intensive Care Medicine

Link

https://www.ijccm.org/doi/pdf/10.5005/jp-journals-10071-24450

Reference5 articles.

1. 1. Prayag PS, Soman RN, Panchakshari SP, Ajapuje PS, Mahale NP, Dhupad S, et al. Therapeutic drug monitoring of isavuconazole: Lessons learnt from a real-life setting in a Tertiary Care Center in India. Indian J Crit Care Med 2023;27(4):260–264. DOI: 10.5005/jp-journals-10071-24443.

2. 2. Charlton M, Thompson JP. Pharmacokinetics in sepsis. BJA Educ. 2019;19(1):7–13. DOI: 10.1016/j.bjae.2018.09.006.

3. 3. Astellas. Cresemba (isavuconazonium sulfate): Highlights of Prescribing Information. 2015. Available from: https://www.astellas.us/docs/cresemba.pdf.

4. 4. Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial. Lancet 2016;387(10020):760–769. DOI: 10.1016/S0140-6736(15)01159-9.

5. 5. Perez L, Corne P, Pasquier G, Konecki C, Sadek M, Le Bihan C, et al. Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses. J Fungi (Basel) 2023;9(2):211. DOI: 10.3390/jof9020211.